Invesco NASDAQ Future Gen 200 ETF

QQQS

Market cap $8.92M

Overview Fund Activity

31.87 USD

+0.04

0.13%

At close Updated Sep 17, 4:00 PM EDT

1 day

0.13%

5 days

0.57%

1 month

7.96%

3 months

23.48%

6 months

25.13%

Year to date

9.48%

1 year

17.56%

5 years

25.67%

10 years

25.67%

Financials Asset Management

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

5% more capital invested

Capital invested by funds: $2.07M [Q1] → $2.17M (+$95K) [Q2]

3.24% less ownership

Funds ownership: 28.55% [Q1] → 25.32% (-3.24%) [Q2]

10% less funds holding

Funds holding: 10 [Q1] → 9 (-1) [Q2]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

See Fund Rankings

Financial journalist opinion

Fed Help Could Be on the Way for This ETF

One day doesn't make a trend. But it's hard to ignore the effect Fed Chair Powell's comments made last Friday had on equities, particularly small-caps.

Fed Help Could Be on the Way for This ETF

Keep It Simple With Small-Caps

Small-cap stocks and ETFs appear to be finding solid footing. That's an arguably surprising scenario given the reputation of summer months being trying for equities.

Keep It Simple With Small-Caps

This ETF Is Soaring as Trade Issues Abate

Look now, because small-cap stocks and relevant ETFs are having their long-awaited moments. Following a one-month gain of more than 6%, the Russell 2000 Index is higher by nearly 9.30% for the 90 days ending July 1.

This ETF Is Soaring as Trade Issues Abate

Tap Into Small-Cap Healthcare Opportunity With This ETF

In an extension of a long-running theme, biotechnology stocks are disappointing investors again in 2025. Large-cap gauges addressing the industry have performed mostly in line with the S&P 500.

Tap Into Small-Cap Healthcare Opportunity With This ETF

Valuations, Earnings Power Could Lift Small-Caps This Year

There's roughly 10 months left in 2025. That's ample time for small-caps stocks and related ETFs to potentially deliver on long-awaited outperformance of large-caps counterparts.

Valuations, Earnings Power Could Lift Small-Caps This Year

How To Avoid The Worst Style ETFs For Q1 2025

ETF issuance is profitable for Wall Street, leading to an overwhelming number of ETFs that may not serve investors' best interests. Avoid ETFs with less than $100 million in assets due to inadequate liquidity and higher trading costs. Invest in ETFs with total annual costs below 0.49% to ensure low fees; high fees don't guarantee quality.

How To Avoid The Worst Style ETFs For Q1 2025

M&A Uptick Could Lift This ETF

Some market participants were enthusiastic about President Trump's return to the White House. One reason was the notion that the regulatory environment in Corporate America would become more hospitable.

M&A Uptick Could Lift This ETF

Small-Caps Improvement Could Support This ETF

Small-caps momentum seemingly waned as quickly as it arrived. But some market observers believe smaller stocks are poised to regain their bullishness.

Small-Caps Improvement Could Support This ETF

Zacks Investment Research

4 Low P/E Momentum ETFs for an Uncertain Santa Rally

Uncertainty remains the only certainty as 2025 approaches in the form of Trump and Fed policies.

4 Low P/E Momentum ETFs for an Uncertain Santa Rally

Biotechnology Rebound Might Boost QQQS

Once stalwarts of the healthcare investing realm, biotechnology stocks and related ETFs have been laggards going back to 2021. That's a lengthy run of disappointment that's given some investors pause about embracing the space.

Biotechnology Rebound Might Boost QQQS

See News Rankings

Charts implemented using Lightweight Charts™